Steris | STE - Net Income


Steris reported $213.7M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
3M USD 1.37B 440M Sep/2026
Accuray USD 2.54M 6.49M Dec/2024
Baxter International USD 294M 168M Sep/2026
Becton, Dickinson and Co. USD 696M 319M Sep/2026
Boston Scientific USD 582M 325M Sep/2026
CONMED USD 23.07M 9.24M Jun/2026
Cooper Companies USD 432.8M 510.7M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
Ecolab USD 551.3M 16.4M Sep/2026
Edwards Lifesciences USD 307.5M 65.6M Sep/2026
Fortive USD 172.5M 15.2M Sep/2026
Getinge SEK 839M 177M Jun/2026
Globus Medical USD 141.17M 10.4M Sep/2026
Haemonetics USD 46.3M 13.3M Sep/2026
Idexx Laboratories USD 317.14M 21.27M Sep/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 141.1M 46.1M Sep/2026
Integra LifeSciences USD 14.85M 10.37M Sep/2026
Intuitive Surgical USD 522.8M 295.3M Sep/2026
J&J USD 210M 5.32B Sep/2026
Olympus JPY 19.1B 5.71B Jun/2026
Orthofix International USD -2.22M 20.57M Dec/2025
Owens Minor USD -56.33M 93.95M Dec/2025
ResMed USD 383.43M 15.3M Jun/2026
Steris USD 213.7M 13.6M Sep/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -7.08M 14.08M Sep/2026
Teleflex USD 927.43M 827.73M Sep/2026
Thermo Fisher Scientific USD 1.72B 15M Sep/2026
Zimmer Biomet Holdings USD 191.6M 6.7M Sep/2026